Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables RefundsShares IssuedShares RepurchasedShort-Term Debt issuancesWages, Salaries and Other
Ratios

Amphastar Pharmaceuticals (AMPH) Long-Term Debt Issuances: 2015-2023

Historic Long-Term Debt Issuances for Amphastar Pharmaceuticals (AMPH) over the last 2 years, with Sep 2023 value amounting to $345.0 million.

  • Amphastar Pharmaceuticals' Long-Term Debt Issuances was N/A to $345.0 million in Q3 2023 from the same period last year, while for Sep 2023 it was $351.7 million, marking a year-over-year change of. This contributed to the annual value of $845.0 million for FY2023, which is N/A change from last year.
  • Amphastar Pharmaceuticals' Long-Term Debt Issuances amounted to $345.0 million in Q3 2023, which was up 10,627.61% from $3.2 million recorded in Q4 2020.
  • Amphastar Pharmaceuticals' 5-year Long-Term Debt Issuances high stood at $345.0 million for Q3 2023, and its period low was $3.1 million during Q1 2020.
  • Over the past 1 years, Amphastar Pharmaceuticals' median Long-Term Debt Issuances value was $345.0 million (recorded in 2023), while the average stood at $345.0 million.